| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 02/22/1994 | US5288854 Antiinflammatory agents |
| 02/22/1994 | US5288614 Method for the detection of malignant diseases |
| 02/22/1994 | US5288490 Anticoagulants having no side effects; immobilizing on the surface of the thrombus to effect lysis |
| 02/17/1994 | WO1994003620A2 Method of increasing expression of viral proteins |
| 02/17/1994 | WO1994003615A1 Expression of recombinant fusion proteins in attenuated bacteria |
| 02/17/1994 | WO1994003208A1 Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them |
| 02/17/1994 | WO1993018054A3 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 02/15/1994 | US5286850 Antibody DTPA-type ligand conjugates |
| 02/15/1994 | US5286628 Monoclonal antibodies to mite allergen and the use thereof |
| 02/15/1994 | US5286487 Covalent angiogenin/RNase hybrids |
| 02/15/1994 | US5286484 Bactericides |
| 02/15/1994 | CA1327096C Peptides corresponding to antigenic and immunogenic determinants of major neutralizing proteins of rotaviruses |
| 02/08/1994 | US5284935 Major histocompatibility complex |
| 02/08/1994 | US5284933 Fusion protein linked to affinity protein having two or more neighboring histidines |
| 02/08/1994 | US5284764 Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3 |
| 02/08/1994 | US5284756 Treatment of bone disorders |
| 02/08/1994 | US5284746 Methods of producing hybrid G protein-coupled receptors |
| 02/03/1994 | WO1994002512A1 Carboxy terminal il-6 muteins |
| 02/03/1994 | WO1994002510A2 Analogs of pth |
| 02/03/1994 | CA2140132A1 Carboxy terminal il-6 muteins |
| 02/02/1994 | EP0581108A2 Bispecific antibody reactive with sialyl-Lea antigen and CD3 |
| 02/02/1994 | EP0580758A1 Anti-human immunodeficiency virus recombinant antibodies |
| 02/02/1994 | EP0580737A1 Heterodimeric receptor libraries using phagemids |
| 02/02/1994 | EP0211047B1 Arab promoters and method of producing polypeptides, includinn cecropins, by microbiological techniques |
| 02/01/1994 | US5283344 Coupling method using selective amination of maleimide |
| 02/01/1994 | US5283321 Polypeptide compound which binds to glyco-conjugates and to artificial pertussis toxin antigen |
| 01/31/1994 | CA2101468A1 Composition for isolating apamin receptors, apamin binding protein, and uses thereof |
| 01/26/1994 | EP0423301B1 Synthetic peptides of the conjugate of ubiquitine and histone h2a |
| 01/25/1994 | CA1326459C Diagnostic peptides of human papilloma virus |
| 01/20/1994 | WO1994001776A1 Assay for chagas' disease and reagents for its use |
| 01/20/1994 | WO1994001567A1 Process for immobilizing enzymes to the cell wall of a microbial cell by producing a fusion protein |
| 01/20/1994 | WO1994001558A2 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor |
| 01/20/1994 | WO1994001464A1 Leukaemia inhibitory factor-binding protein |
| 01/20/1994 | WO1994001451A2 Method for modification of recombinant polypeptides |
| 01/20/1994 | WO1993023540A3 Improved methods for the preparation of endotoxin-binding proteins |
| 01/20/1994 | CA2140002A1 A chemical method for selective modification of the n- and/or c-terminal amino acid .alpha.-carbon reactive group of a recombinant polypeptide or a portion thereof |
| 01/20/1994 | CA2139504A1 Leukaemia inhibitory factor-binding protein |
| 01/20/1994 | CA2137462A1 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor |
| 01/19/1994 | EP0578819A1 Icam-related protein |
| 01/19/1994 | EP0172194B1 Control systems for recombinant manipulations |
| 01/18/1994 | US5279958 Surface protein of basal epidermal cells, antibodies capable of recognizing said protein, and their use, and hybrid cellular stocks capable of secreting such antibodies |
| 01/18/1994 | US5279954 Coupling a nucleophile to protein; binding to other adjuvants |
| 01/15/1994 | CA2100377A1 Bispecific antibody |
| 01/12/1994 | EP0578293A1 E-coli P-fimbrine as immunogenic carrier system against GnRH |
| 01/12/1994 | EP0578145A1 Compounds and process for photoactivable labelling of biomolecules |
| 01/12/1994 | EP0577894A1 Design, construction and expression of chimeric proteins for development of vaccines and diagnostic reagents |
| 01/12/1994 | EP0577814A1 Novel heterodimeric nuclear receptors proteins, genes encoding same, and usage thereof |
| 01/12/1994 | EP0577605A1 G protein-coupled glutamate receptors |
| 01/12/1994 | EP0423228B1 Immunoconjugates for cancer diagnosis and therapy |
| 01/12/1994 | EP0330661B1 Fusion proteins and particles |
| 01/12/1994 | EP0329671B1 Particulate hybrid hiv antigens |
| 01/11/1994 | US5278045 Method and compositions to screen compounds for enhancement of the cholinergic, dopaminergic and serotonergic function |
| 01/11/1994 | CA1326109C Sv40 expression vector containing hbxag as an expression marker |
| 01/11/1994 | CA1326106C Production of proteins in active forms |
| 01/06/1994 | WO1994000601A1 Method for detecting pre-cancerous or cancerous cells using p90 antibodies or probes |
| 01/06/1994 | WO1994000594A1 Methods for using cks fusion proteins |
| 01/06/1994 | WO1994000590A1 Cloning and expression of gonadotropin-releasing hormone receptor |
| 01/06/1994 | WO1994000575A1 Immediate early hsv-2 viral protein icp27 as vaccine |
| 01/06/1994 | WO1994000493A1 Membrane-associated immunogens of mycobacteria |
| 01/06/1994 | WO1994000143A1 Blocking intercellular interactions with cd43 chimeric molecules |
| 01/06/1994 | WO1993023434A3 Bpi-immunoglobulin fusion proteins |
| 01/06/1994 | WO1993021331A3 Polysaccharide binding fusion proteins and conjugates |
| 01/06/1994 | CA2138996A1 Immediate early hsv-2 viral protein icp27 as vaccine |
| 01/06/1994 | CA2138970A1 Membrane-associated immunogens of mycobacteria |
| 01/06/1994 | CA2136765A1 Methods for using cks fusion proteins |
| 01/05/1994 | EP0576623A1 Binding domains in notch and delta proteins |
| 12/29/1993 | EP0575553A1 Recombinant hybrid porin epitopes |
| 12/29/1993 | EP0575498A1 THE $i(TRK) TYROSINE KINASE RECEPTOR IS THE PHYSIOLOGICAL RECEPTOR FOR NERVE GROWTH FACTOR |
| 12/29/1993 | EP0192671B1 Minactivin |
| 12/28/1993 | US5273884 Polypetides, antigens or vaccines protective against babesiosis |
| 12/28/1993 | CA1325612C Polypeptides and derivatives thereof as well as their use in pharmaceutical and diagnostic compositions |
| 12/23/1993 | WO1993025690A1 Recombinant pseudomonas exotoxin with increased activity |
| 12/23/1993 | WO1993025689A1 Cloning of gene encoding the gp28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications |
| 12/23/1993 | WO1993025688A1 Recombinant production of saporin-containing proteins |
| 12/23/1993 | WO1993025682A2 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
| 12/23/1993 | WO1993025583A2 Proteinoid carriers and methods for preparation and use thereof |
| 12/23/1993 | WO1993025576A2 Peptides having platelet-derived growth factor (pdgf) activity |
| 12/23/1993 | WO1993025237A1 Chimeric anti-cea antibody |
| 12/23/1993 | WO1993025228A1 Cytotoxins specific for gm-csf receptor-bearing cells |
| 12/23/1993 | WO1993025210A1 Diphtheria toxin vaccines |
| 12/23/1993 | CA2138146A1 Proteinoid carriers and methods for preparation and use thereof |
| 12/23/1993 | CA2138038A1 Recombinant production of saporin-containing proteins |
| 12/23/1993 | CA2137547A1 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
| 12/23/1993 | CA2137367A1 Peptides having platelet-derived growth factor (pdgf) activity |
| 12/23/1993 | CA2136724A1 Recombinant pseudomonas exotoxin with increased activity |
| 12/23/1993 | CA2115346A1 Chimeric anti-cea antibody |
| 12/22/1993 | EP0574512A1 Redirection of cellular immunity by receptor chimeras |
| 12/22/1993 | EP0574506A1 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
| 12/22/1993 | EP0574395A1 Cytokine immunoconjugates |
| 12/22/1993 | CN1079825A Immunochemical detection of in vivo advanced glycosylation endproducts |
| 12/21/1993 | US5272263 DNA sequences encoding vascular cell adhesion molecules (VCAMS) |
| 12/18/1993 | CA2084136A1 Design, construction and expression of chimeric proteins for development of vaccines and diagnostic reagents |
| 12/15/1993 | EP0573613A1 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences |
| 12/15/1993 | EP0573551A1 Serine-rich peptide linkers |
| 12/14/1993 | US5270181 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
| 12/14/1993 | US5270030 Fibrin binding domain polypeptide and method of producing |
| 12/09/1993 | WO1993024630A1 Reagent for agglutination assays |
| 12/09/1993 | WO1993024531A1 Bnp antibody and immunoassay using it |
| 12/09/1993 | WO1993024530A1 Serum amyloid a protein |
| 12/09/1993 | CA2136719A1 Serum amyloid a protein |